Education
About Us
Working with TipRanks
Follow Us
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
JUBLPHARMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹701.40 - ₹1,309.00
Previous CloseN/A
Volume282.20K
Average Volume (3M)14.56K
Market Cap
₹191.69B
Enterprise Value₹207.97B
Total Cash (Recent Filing)₹10.89B
Total Debt (Recent Filing)₹27.31B
Price to Earnings (P/E)22.7
Beta1.15
Next Earnings
Jul 18, 2025EPS Estimate
6.4Next Dividend Ex-Date
Jul 25, 2025Dividend Yield0.41%
Share Statistics
EPS (TTM)N/A
Shares Outstanding159,281,140
10 Day Avg. Volume7,967
30 Day Avg. Volume14,559
Financial Highlights & Ratios
PEG Ratio0.67
Price to Book (P/B)3.05
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jubilant Pharmova Limited News
PremiumCompany Announcements
Jubilant Pharmova Ensures Compliance with SEBI Regulations for Q2 2025
PremiumCompany Announcements
Jubilant Pharmova Completes Postal Ballot Notice Dispatch
PremiumCompany Announcements
Jubilant Pharmova’s Chairman Cleared of Allegations, No Impact on Operations
PremiumCompany Announcements
Jubilant Pharmova’s Promoters Declare No Share Encumbrances for FY 2025
PremiumCompany Announcements
Jubilant Pharmova Releases Transcript of Investor Meet
PremiumCompany Announcements
Jubilant Pharmova Releases Investor Meet Audio RecordingJUBLPHARMA FAQ
What was Jubilant Pharmova Limited’s price range in the past 12 months?
Jubilant Pharmova Limited lowest stock price was ₹701.40 and its highest was ₹1309.00 in the past 12 months.
What is Jubilant Pharmova Limited’s market cap?
Jubilant Pharmova Limited’s market cap is ₹191.69B.
When is Jubilant Pharmova Limited’s upcoming earnings report date?
Jubilant Pharmova Limited’s upcoming earnings report date is Jul 18, 2025 which is yesterday.
How were Jubilant Pharmova Limited’s earnings last quarter?
Currently, no data Available
Is Jubilant Pharmova Limited overvalued?
According to Wall Street analysts Jubilant Pharmova Limited’s price is currently Overvalued.
Does Jubilant Pharmova Limited pay dividends?
Jubilant Pharmova Limited pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.41%. See more information on Jubilant Pharmova Limited dividends here
What is Jubilant Pharmova Limited’s EPS estimate?
Jubilant Pharmova Limited’s EPS estimate is 6.4.
How many shares outstanding does Jubilant Pharmova Limited have?
Jubilant Pharmova Limited has 159,281,140 shares outstanding.
What happened to Jubilant Pharmova Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jubilant Pharmova Limited?
Currently, no hedge funds are holding shares in IN:JUBLPHARMA
Company Description
Jubilant Pharmova Limited
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Caplin Point Laboratories Limited
―
Granules India Limited
―
NATCO Pharma Limited
―
Neuland Laboratories Ltd.
―